Stemtech (STEK) EBITDA (2012 - 2025)

Stemtech has disclosed EBITDA across 14 years of filings, most recently posting -$1.3 million for Q4 2025.

• EBITDA for Q4 2025 came in at -$1.3 million, down 445.02% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.8 million (up 63.49% YoY), and the FY2025 annual result was -$4.0 million, up 1.61% from the prior year.
• EBITDA came in at -$1.3 million for Q4 2025 at Stemtech, down from -$127115.0 in the prior quarter.
• In the past five years, EBITDA ranged from a high of $17.0 million in Q3 2022 to a low of -$24.6 million in Q2 2022.
• The 5-year median for EBITDA is -$669622.5 (2022), against an average of -$1.4 million.
• Peak annual rise in EBITDA reached 393.92% in 2022, while the deepest fall reached 8215.81% in 2022.
• Stemtech's EBITDA stood at -$584502.0 in 2021, then surged by 84.14% to -$92699.0 in 2022, then tumbled by 1208.61% to -$1.2 million in 2023, then soared by 130.16% to $365863.0 in 2024, then sank by 445.02% to -$1.3 million in 2025.
• The last three EBITDA figures came in at -$1.3 million (Q4 2025), -$127115.0 (Q3 2025), and $389146.0 (Q2 2025), per Business Quant data.